世界のアンドロゲン除去療法(ADT)市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Androgen Deprivation Therapy (ADT) Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5078
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、107ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療機器

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、アンドロゲン除去療法(ADT)の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（医学、外科手術、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・アンドロゲン除去療法(ADT)の市場動向
・企業の競争状況、市場シェア
・アンドロゲン除去療法(ADT)の種類別市場規模と予測2016-2027（医学、外科手術、その他）
・アンドロゲン除去療法(ADT)の用途別市場規模と予測2016-2027（病院、診療所、その他）
・アンドロゲン除去療法(ADT)の北米市場規模2016-2027（アメリカ、カナダ）
・アンドロゲン除去療法(ADT)の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・アンドロゲン除去療法(ADT)のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・アンドロゲン除去療法(ADT)の中南米市場規模2016-2027（メキシコ、ブラジル）
・アンドロゲン除去療法(ADT)の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Pfizer、Astellas Pharma、Johnson & Johnson、Novartis International、Merck、Veru、Sanofi、GlaxoSmithKline、Bayer、Orion、AstraZeneca）
・結論

Androgen Deprivation Therapy is an antihormone therapy whose main use is in treating prostate cancer.

Market Analysis and Insights: Global Androgen Deprivation Therapy (ADT) Market
The global Androgen Deprivation Therapy (ADT) market size is projected to reach US$ 8369.7 million by 2027, from US$ 5773.1 million in 2020, at a CAGR of 5.0% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Androgen Deprivation Therapy (ADT) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Androgen Deprivation Therapy (ADT) market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Androgen Deprivation Therapy (ADT) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Androgen Deprivation Therapy (ADT) market.

Global Androgen Deprivation Therapy (ADT) Scope and Market Size
Androgen Deprivation Therapy (ADT) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Androgen Deprivation Therapy (ADT) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Medicine
Surgery
Other

Segment by Application
Hospital
Clinic
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Pfizer
Astellas Pharma
Johnson & Johnson
Novartis International
Merck
Veru
Sanofi
GlaxoSmithKline
Bayer
Orion
AstraZeneca

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Androgen Deprivation Therapy (ADT) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Medicine
1.2.3 Surgery
1.2.4 Other
1.3 Market by Application
1.3.1 Global Androgen Deprivation Therapy (ADT) Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Androgen Deprivation Therapy (ADT) Market Perspective (2016-2027)
2.2 Androgen Deprivation Therapy (ADT) Growth Trends by Regions
2.2.1 Androgen Deprivation Therapy (ADT) Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Androgen Deprivation Therapy (ADT) Historic Market Share by Regions (2016-2021)
2.2.3 Androgen Deprivation Therapy (ADT) Forecasted Market Size by Regions (2022-2027)
2.3 Androgen Deprivation Therapy (ADT) Industry Dynamic
2.3.1 Androgen Deprivation Therapy (ADT) Market Trends
2.3.2 Androgen Deprivation Therapy (ADT) Market Drivers
2.3.3 Androgen Deprivation Therapy (ADT) Market Challenges
2.3.4 Androgen Deprivation Therapy (ADT) Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Androgen Deprivation Therapy (ADT) Players by Revenue
3.1.1 Global Top Androgen Deprivation Therapy (ADT) Players by Revenue (2016-2021)
3.1.2 Global Androgen Deprivation Therapy (ADT) Revenue Market Share by Players (2016-2021)
3.2 Global Androgen Deprivation Therapy (ADT) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Androgen Deprivation Therapy (ADT) Revenue
3.4 Global Androgen Deprivation Therapy (ADT) Market Concentration Ratio
3.4.1 Global Androgen Deprivation Therapy (ADT) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Androgen Deprivation Therapy (ADT) Revenue in 2020
3.5 Androgen Deprivation Therapy (ADT) Key Players Head office and Area Served
3.6 Key Players Androgen Deprivation Therapy (ADT) Product Solution and Service
3.7 Date of Enter into Androgen Deprivation Therapy (ADT) Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Androgen Deprivation Therapy (ADT) Breakdown Data by Type
4.1 Global Androgen Deprivation Therapy (ADT) Historic Market Size by Type (2016-2021)
4.2 Global Androgen Deprivation Therapy (ADT) Forecasted Market Size by Type (2022-2027)

5 Androgen Deprivation Therapy (ADT) Breakdown Data by Application
5.1 Global Androgen Deprivation Therapy (ADT) Historic Market Size by Application (2016-2021)
5.2 Global Androgen Deprivation Therapy (ADT) Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Androgen Deprivation Therapy (ADT) Market Size (2016-2027)
6.2 North America Androgen Deprivation Therapy (ADT) Market Size by Type
6.2.1 North America Androgen Deprivation Therapy (ADT) Market Size by Type (2016-2021)
6.2.2 North America Androgen Deprivation Therapy (ADT) Market Size by Type (2022-2027)
6.2.3 North America Androgen Deprivation Therapy (ADT) Market Size by Type (2016-2027)
6.3 North America Androgen Deprivation Therapy (ADT) Market Size by Application
6.3.1 North America Androgen Deprivation Therapy (ADT) Market Size by Application (2016-2021)
6.3.2 North America Androgen Deprivation Therapy (ADT) Market Size by Application (2022-2027)
6.3.3 North America Androgen Deprivation Therapy (ADT) Market Size by Application (2016-2027)
6.4 North America Androgen Deprivation Therapy (ADT) Market Size by Country
6.4.1 North America Androgen Deprivation Therapy (ADT) Market Size by Country (2016-2021)
6.4.2 North America Androgen Deprivation Therapy (ADT) Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Androgen Deprivation Therapy (ADT) Market Size (2016-2027)
7.2 Europe Androgen Deprivation Therapy (ADT) Market Size by Type
7.2.1 Europe Androgen Deprivation Therapy (ADT) Market Size by Type (2016-2021)
7.2.2 Europe Androgen Deprivation Therapy (ADT) Market Size by Type (2022-2027)
7.2.3 Europe Androgen Deprivation Therapy (ADT) Market Size by Type (2016-2027)
7.3 Europe Androgen Deprivation Therapy (ADT) Market Size by Application
7.3.1 Europe Androgen Deprivation Therapy (ADT) Market Size by Application (2016-2021)
7.3.2 Europe Androgen Deprivation Therapy (ADT) Market Size by Application (2022-2027)
7.3.3 Europe Androgen Deprivation Therapy (ADT) Market Size by Application (2016-2027)
7.4 Europe Androgen Deprivation Therapy (ADT) Market Size by Country
7.4.1 Europe Androgen Deprivation Therapy (ADT) Market Size by Country (2016-2021)
7.4.2 Europe Androgen Deprivation Therapy (ADT) Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size (2016-2027)
8.2 Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size by Type
8.2.1 Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size by Type (2016-2027)
8.3 Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size by Application
8.3.1 Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size by Application (2016-2027)
8.4 Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size by Region
8.4.1 Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Androgen Deprivation Therapy (ADT) Market Size (2016-2027)
9.2 Latin America Androgen Deprivation Therapy (ADT) Market Size by Type
9.2.1 Latin America Androgen Deprivation Therapy (ADT) Market Size by Type (2016-2021)
9.2.2 Latin America Androgen Deprivation Therapy (ADT) Market Size by Type (2022-2027)
9.2.3 Latin America Androgen Deprivation Therapy (ADT) Market Size by Type (2016-2027)
9.3 Latin America Androgen Deprivation Therapy (ADT) Market Size by Application
9.3.1 Latin America Androgen Deprivation Therapy (ADT) Market Size by Application (2016-2021)
9.3.2 Latin America Androgen Deprivation Therapy (ADT) Market Size by Application (2022-2027)
9.3.3 Latin America Androgen Deprivation Therapy (ADT) Market Size by Application (2016-2027)
9.4 Latin America Androgen Deprivation Therapy (ADT) Market Size by Country
9.4.1 Latin America Androgen Deprivation Therapy (ADT) Market Size by Country (2016-2021)
9.4.2 Latin America Androgen Deprivation Therapy (ADT) Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size (2016-2027)
10.2 Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size by Type
10.2.1 Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size by Type (2016-2027)
10.3 Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size by Application
10.3.1 Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size by Application (2016-2027)
10.4 Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size by Country
10.4.1 Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Androgen Deprivation Therapy (ADT) Introduction
11.1.4 Pfizer Revenue in Androgen Deprivation Therapy (ADT) Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Astellas Pharma
11.2.1 Astellas Pharma Company Details
11.2.2 Astellas Pharma Business Overview
11.2.3 Astellas Pharma Androgen Deprivation Therapy (ADT) Introduction
11.2.4 Astellas Pharma Revenue in Androgen Deprivation Therapy (ADT) Business (2016-2021)
11.2.5 Astellas Pharma Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Details
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Androgen Deprivation Therapy (ADT) Introduction
11.3.4 Johnson & Johnson Revenue in Androgen Deprivation Therapy (ADT) Business (2016-2021)
11.3.5 Johnson & Johnson Recent Development
11.4 Novartis International
11.4.1 Novartis International Company Details
11.4.2 Novartis International Business Overview
11.4.3 Novartis International Androgen Deprivation Therapy (ADT) Introduction
11.4.4 Novartis International Revenue in Androgen Deprivation Therapy (ADT) Business (2016-2021)
11.4.5 Novartis International Recent Development
11.5 Merck
11.5.1 Merck Company Details
11.5.2 Merck Business Overview
11.5.3 Merck Androgen Deprivation Therapy (ADT) Introduction
11.5.4 Merck Revenue in Androgen Deprivation Therapy (ADT) Business (2016-2021)
11.5.5 Merck Recent Development
11.6 Veru
11.6.1 Veru Company Details
11.6.2 Veru Business Overview
11.6.3 Veru Androgen Deprivation Therapy (ADT) Introduction
11.6.4 Veru Revenue in Androgen Deprivation Therapy (ADT) Business (2016-2021)
11.6.5 Veru Recent Development
11.7 Sanofi
11.7.1 Sanofi Company Details
11.7.2 Sanofi Business Overview
11.7.3 Sanofi Androgen Deprivation Therapy (ADT) Introduction
11.7.4 Sanofi Revenue in Androgen Deprivation Therapy (ADT) Business (2016-2021)
11.7.5 Sanofi Recent Development
11.8 GlaxoSmithKline
11.8.1 GlaxoSmithKline Company Details
11.8.2 GlaxoSmithKline Business Overview
11.8.3 GlaxoSmithKline Androgen Deprivation Therapy (ADT) Introduction
11.8.4 GlaxoSmithKline Revenue in Androgen Deprivation Therapy (ADT) Business (2016-2021)
11.8.5 GlaxoSmithKline Recent Development
11.9 Bayer
11.9.1 Bayer Company Details
11.9.2 Bayer Business Overview
11.9.3 Bayer Androgen Deprivation Therapy (ADT) Introduction
11.9.4 Bayer Revenue in Androgen Deprivation Therapy (ADT) Business (2016-2021)
11.9.5 Bayer Recent Development
11.10 Orion
11.10.1 Orion Company Details
11.10.2 Orion Business Overview
11.10.3 Orion Androgen Deprivation Therapy (ADT) Introduction
11.10.4 Orion Revenue in Androgen Deprivation Therapy (ADT) Business (2016-2021)
11.10.5 Orion Recent Development
11.11 AstraZeneca
11.11.1 AstraZeneca Company Details
11.11.2 AstraZeneca Business Overview
11.11.3 AstraZeneca Androgen Deprivation Therapy (ADT) Introduction
11.11.4 AstraZeneca Revenue in Androgen Deprivation Therapy (ADT) Business (2016-2021)
11.11.5 AstraZeneca Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Androgen Deprivation Therapy (ADT) Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Medicine
Table 3. Key Players of Surgery
Table 4. Key Players of Other
Table 5. Global Androgen Deprivation Therapy (ADT) Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Androgen Deprivation Therapy (ADT) Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Androgen Deprivation Therapy (ADT) Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Androgen Deprivation Therapy (ADT) Market Share by Regions (2016-2021)
Table 9. Global Androgen Deprivation Therapy (ADT) Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Androgen Deprivation Therapy (ADT) Market Share by Regions (2022-2027)
Table 11. Androgen Deprivation Therapy (ADT) Market Trends
Table 12. Androgen Deprivation Therapy (ADT) Market Drivers
Table 13. Androgen Deprivation Therapy (ADT) Market Challenges
Table 14. Androgen Deprivation Therapy (ADT) Market Restraints
Table 15. Global Androgen Deprivation Therapy (ADT) Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Androgen Deprivation Therapy (ADT) Market Share by Players (2016-2021)
Table 17. Global Top Androgen Deprivation Therapy (ADT) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Androgen Deprivation Therapy (ADT) as of 2020)
Table 18. Ranking of Global Top Androgen Deprivation Therapy (ADT) Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Androgen Deprivation Therapy (ADT) Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Androgen Deprivation Therapy (ADT) Product Solution and Service
Table 22. Date of Enter into Androgen Deprivation Therapy (ADT) Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Androgen Deprivation Therapy (ADT) Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Androgen Deprivation Therapy (ADT) Revenue Market Share by Type (2016-2021)
Table 26. Global Androgen Deprivation Therapy (ADT) Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Androgen Deprivation Therapy (ADT) Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Androgen Deprivation Therapy (ADT) Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Androgen Deprivation Therapy (ADT) Revenue Market Share by Application (2016-2021)
Table 30. Global Androgen Deprivation Therapy (ADT) Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Androgen Deprivation Therapy (ADT) Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Androgen Deprivation Therapy (ADT) Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Androgen Deprivation Therapy (ADT) Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Androgen Deprivation Therapy (ADT) Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Androgen Deprivation Therapy (ADT) Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Androgen Deprivation Therapy (ADT) Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Androgen Deprivation Therapy (ADT) Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Androgen Deprivation Therapy (ADT) Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Androgen Deprivation Therapy (ADT) Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Androgen Deprivation Therapy (ADT) Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Androgen Deprivation Therapy (ADT) Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Androgen Deprivation Therapy (ADT) Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Androgen Deprivation Therapy (ADT) Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Androgen Deprivation Therapy (ADT) Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Androgen Deprivation Therapy (ADT) Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Androgen Deprivation Therapy (ADT) Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Androgen Deprivation Therapy (ADT) Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Androgen Deprivation Therapy (ADT) Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Androgen Deprivation Therapy (ADT) Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size by Country (2022-2027) & (US$ Million)
Table 62. Pfizer Company Details
Table 63. Pfizer Business Overview
Table 64. Pfizer Androgen Deprivation Therapy (ADT) Product
Table 65. Pfizer Revenue in Androgen Deprivation Therapy (ADT) Business (2016-2021) & (US$ Million)
Table 66. Pfizer Recent Development
Table 67. Astellas Pharma Company Details
Table 68. Astellas Pharma Business Overview
Table 69. Astellas Pharma Androgen Deprivation Therapy (ADT) Product
Table 70. Astellas Pharma Revenue in Androgen Deprivation Therapy (ADT) Business (2016-2021) & (US$ Million)
Table 71. Astellas Pharma Recent Development
Table 72. Johnson & Johnson Company Details
Table 73. Johnson & Johnson Business Overview
Table 74. Johnson & Johnson Androgen Deprivation Therapy (ADT) Product
Table 75. Johnson & Johnson Revenue in Androgen Deprivation Therapy (ADT) Business (2016-2021) & (US$ Million)
Table 76. Johnson & Johnson Recent Development
Table 77. Novartis International Company Details
Table 78. Novartis International Business Overview
Table 79. Novartis International Androgen Deprivation Therapy (ADT) Product
Table 80. Novartis International Revenue in Androgen Deprivation Therapy (ADT) Business (2016-2021) & (US$ Million)
Table 81. Novartis International Recent Development
Table 82. Merck Company Details
Table 83. Merck Business Overview
Table 84. Merck Androgen Deprivation Therapy (ADT) Product
Table 85. Merck Revenue in Androgen Deprivation Therapy (ADT) Business (2016-2021) & (US$ Million)
Table 86. Merck Recent Development
Table 87. Veru Company Details
Table 88. Veru Business Overview
Table 89. Veru Androgen Deprivation Therapy (ADT) Product
Table 90. Veru Revenue in Androgen Deprivation Therapy (ADT) Business (2016-2021) & (US$ Million)
Table 91. Veru Recent Development
Table 92. Sanofi Company Details
Table 93. Sanofi Business Overview
Table 94. Sanofi Androgen Deprivation Therapy (ADT) Product
Table 95. Sanofi Revenue in Androgen Deprivation Therapy (ADT) Business (2016-2021) & (US$ Million)
Table 96. Sanofi Recent Development
Table 97. GlaxoSmithKline Company Details
Table 98. GlaxoSmithKline Business Overview
Table 99. GlaxoSmithKline Revenue in Androgen Deprivation Therapy (ADT) Business (2016-2021) & (US$ Million)
Table 100. GlaxoSmithKline Recent Development
Table 101. Bayer Company Details
Table 102. Bayer Business Overview
Table 103. Bayer Androgen Deprivation Therapy (ADT) Product
Table 104. Bayer Revenue in Androgen Deprivation Therapy (ADT) Business (2016-2021) & (US$ Million)
Table 105. Bayer Recent Development
Table 106. Orion Company Details
Table 107. Orion Business Overview
Table 108. Orion Androgen Deprivation Therapy (ADT) Product
Table 109. Orion Revenue in Androgen Deprivation Therapy (ADT) Business (2016-2021) & (US$ Million)
Table 110. Orion Recent Development
Table 111. AstraZeneca Company Details
Table 112. AstraZeneca Business Overview
Table 113. AstraZeneca Androgen Deprivation Therapy (ADT) Product
Table 114. AstraZeneca Revenue in Androgen Deprivation Therapy (ADT) Business (2016-2021) & (US$ Million)
Table 115. AstraZeneca Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Androgen Deprivation Therapy (ADT) Market Share by Type: 2020 VS 2027
Figure 2. Medicine Features
Figure 3. Surgery Features
Figure 4. Other Features
Figure 5. Global Androgen Deprivation Therapy (ADT) Market Share by Application: 2020 VS 2027
Figure 6. Hospital Case Studies
Figure 7. Clinic Case Studies
Figure 8. Other Case Studies
Figure 9. Androgen Deprivation Therapy (ADT) Report Years Considered
Figure 10. Global Androgen Deprivation Therapy (ADT) Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Androgen Deprivation Therapy (ADT) Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Androgen Deprivation Therapy (ADT) Market Share by Regions: 2020 VS 2027
Figure 13. Global Androgen Deprivation Therapy (ADT) Market Share by Regions (2022-2027)
Figure 14. Global Androgen Deprivation Therapy (ADT) Market Share by Players in 2020
Figure 15. Global Top Androgen Deprivation Therapy (ADT) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Androgen Deprivation Therapy (ADT) as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Androgen Deprivation Therapy (ADT) Revenue in 2020
Figure 17. Global Androgen Deprivation Therapy (ADT) Revenue Market Share by Type (2016-2021)
Figure 18. Global Androgen Deprivation Therapy (ADT) Revenue Market Share by Type (2022-2027)
Figure 19. North America Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Androgen Deprivation Therapy (ADT) Market Share by Type (2016-2027)
Figure 21. North America Androgen Deprivation Therapy (ADT) Market Share by Application (2016-2027)
Figure 22. North America Androgen Deprivation Therapy (ADT) Market Share by Country (2016-2027)
Figure 23. United States Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Androgen Deprivation Therapy (ADT) Market Share by Type (2016-2027)
Figure 27. Europe Androgen Deprivation Therapy (ADT) Market Share by Application (2016-2027)
Figure 28. Europe Androgen Deprivation Therapy (ADT) Market Share by Country (2016-2027)
Figure 29. Germany Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Androgen Deprivation Therapy (ADT) Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Androgen Deprivation Therapy (ADT) Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Androgen Deprivation Therapy (ADT) Market Share by Region (2016-2027)
Figure 39. China Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Androgen Deprivation Therapy (ADT) Market Share by Type (2016-2027)
Figure 47. Latin America Androgen Deprivation Therapy (ADT) Market Share by Application (2016-2027)
Figure 48. Latin America Androgen Deprivation Therapy (ADT) Market Share by Country (2016-2027)
Figure 49. Mexico Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Androgen Deprivation Therapy (ADT) Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Androgen Deprivation Therapy (ADT) Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Androgen Deprivation Therapy (ADT) Market Share by Country (2016-2027)
Figure 55. Turkey Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Pfizer Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2016-2021)
Figure 59. Astellas Pharma Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2016-2021)
Figure 60. Johnson & Johnson Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2016-2021)
Figure 61. Novartis International Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2016-2021)
Figure 62. Merck Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2016-2021)
Figure 63. Veru Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2016-2021)
Figure 64. Sanofi Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2016-2021)
Figure 65. GlaxoSmithKline Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2016-2021)
Figure 66. Bayer Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2016-2021)
Figure 67. Orion Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2016-2021)
Figure 68. AstraZeneca Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

以下、関連資料のご紹介

世界のアンドロゲン補充療法市場規模・現状・予測（2021年-2027年）

Global Androgen Replacement Therapy Market Size, Status and Forecast 2021-2027
QFJ1-3804 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、アンドロゲン補充療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ジェル、注射、パッチ、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国...

世界の遺伝子治療医薬品（GTMP）市場規模・現状・予測（2021年-2027年）

Global Gene Therapy Medicinal Products (GTMP) Market Size, Status and Forecast 2021-2027
QFJ1-5750 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、遺伝子治療医薬品（GTMP）の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、注射）、用途別市場規模（がん、単発性、感染症、循環器疾患、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、...

世界の強度変調陽子線治療（IMPT）市場規模・現状・予測（2021年-2027年）

Global Intensity-Modulated Proton Therapy (IMPT) Market Size, Status and Forecast 2021-2027
QFJ1-5215 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、強度変調陽子線治療（IMPT）の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（シンクロトロン型、サイクロトロン型、同期サイクロトロン型、線形加速器型）、用途別市場規模（病院、陽子線治療センター、その他...

世界のペプチド受容体放射性核種療法（PRRT）市場規模・現状・予測（2021年-2027年）

Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size, Status and Forecast 2021-2027
QFJ1-5936 2021年6月 86Pages
QYResearch社発行の本調査レポートでは、ペプチド受容体放射性核種療法（PRRT）の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（胃腸膵臓神経内分泌腫瘍、前腸神経内分泌腫瘍、中腸神経内分泌腫瘍、後腸神経内分泌腫瘍）、用途別市場規模（病院薬局、...

世界のゴーシェ病＆ポンペ病酵素補充療法（ERT）市場規模・現状・予測（2021年-2027年）

Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size, Status and Forecast 2021-2027
QFJ1-4244 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、ゴーシェ病＆ポンペ病酵素補充療法（ERT）の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ゴーシェ病、ポンペ病）、用途別市場規模（乳児、子供、大人）、主要地域別市場規模（北米、アメリカ、欧州、アジア、...

世界のがんにおける人工知能（AI）市場規模・現状・予測（2021年-2027年）

Global Artificial Intelligence (AI) in Cancer Market Size, Status and Forecast 2021-2027
QFJ1-3857 2021年6月 123Pages
QYResearch社発行の本調査レポートでは、がんにおける人工知能（AI）の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（外科、放射線療法、化学療法、免疫療法、光線療法、遺伝子治療、ソノダイナミック療法）、用途別市場規模（診断、治療、予後、健康管...

世界のがんホルモン療法剤市場規模・現状・予測（2021年-2027年）

Global Cancer Hormone Therapy Drugs Market Size, Status and Forecast 2021-2027
QFJ1-3955 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、がんホルモン療法剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（タモキシフェン、アロマターゼ阻害剤、抗アンドロゲン剤、アンドロゲン合成阻害剤、その他）、用途別市場規模（乳がん、前立腺がん）、主要地域...

アンドロゲン補充療法のグローバル市場調査 2019年

Global Androgen Replacement Therapy Market Professional Survey Report 2019
QYR9NV00718 2019年11月12日 113Pages
※本調査レポートは、アンドロゲン補充療法の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、ゲル、注射剤、パッチ、その他に、用途別には、病院、クリニック、その他に...

世界の重粒子線治療市場規模・現状・予測（2021年-2027年）

Global Heavy Ion Therapy Market Size, Status and Forecast 2021-2027
QFJ1-5188 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、重粒子線治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（機器、サービス）、用途別市場規模（科学研究所、医療、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東...

世界の活性化部分トロンボプラスチン時間検査（APTT検査）市場規模・現状・予測（2021年-2027年）

Global Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size, Status and Forecast 2021-2027
QFJ1-3755 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、活性化部分トロンボプラスチン時間検査（APTT検査）の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（光学技術、機械技術、電気化学技術）、用途別市場規模（ヘパリン療法モニタリング、凝固因子欠損症スクリー...

世界のアンドロゲン補充療法市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Androgen Replacement Therapy Market The global Androgen Replacement Therapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integri…
アンドロゲン補充療法のグローバル市場調査 2019年 The global Androgen Replacement Therapy market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Androgen Replacement Therapy volume and value at global level, regional level and company level. From a global…
世界の遺伝子治療医学市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Gene Therapy Medicine Market The global Gene Therapy Medicine market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report…
世界のがんホルモン療法剤市場規模・現状・予測（2021年-2027年） Hormone Therapy, (also called hormonal therapy, hormone treatment, or endocrine therapy) is a cancer treatment that blocks or lowers the growth of cancer that uses hormones to grow. Doctors use it to treat some cancers such as breast and prostate cancer. Market Analysis and Insights: Global Cancer H…
世界のコラーゲン修復療法市場規模・現状・予測（2021年-2027年） A collagen facial is a treatment designed to restore the depleted collage in your face and rejuvenate your skin. Market Analysis and Insights: Global Collagen Restoration Therapy Market The global Collagen Restoration Therapy market size is projected to reach US$ XX million by 2027, from US$ XX mill…